baber/WOPTO huggingface dataset:
Patent MD-20010081-A (MD)
Title: Running gear drive of the transport facility
Inventor: BOSTAN ION
IPC: B62D55/00
Filed: 2001-03-27
Abstract: The invention relates to the mechanical engineering, in particular to the transport facilities. The running gear drive of the transport facility includes a frame, onto which there are installed the driving sprockets, rigidly linked with the rotatable body of the precession gearbox.Into the body it is placed the built-up two-ring satellite gear with a trust bearing. The satellite gear parts are linked between them with cams. On one side of the satellite gear it is fixed a central wheel, rigidly coupled with the body, and on the other side it is fixed a central wheel, rigidly coupled with the frame by means of the shaft. The satellite gear is freely installed onto an oblique crank.Claims: 2Fig.: 5
Patent MD-20020154-A (MD)
Title: Process for application of an antibiotic coating onto the bodies with interconnected microcavities, body with coating applied by the said process and utilization thereof
Inventor: VOGT SEBASTIAN
IPC: A61L27/28
Filed: 2002-06-03
Abstract: The process is characterized in that into the microcavities of the nonmetallic bodies is introduced the aqueous solution 1, containing at least one readily water soluble antibiotic from the group of aminoglycosides, tetracyclines, lincosamides, 4-quinolones and then the aqueous solution 2, containing at least one readily water soluble amphiphilic component from the group of alkyl sulphates, alkyl sulphonates, alkyl aryl sulphates, dialkyl aryl sulphates, alkyl aryl sulphonates, dialkyl aryl sulphonates, cycloalkyl sulphates, cycloalkyl sulphonates, alkyl cycloalkyl sulphates and in the interval between introduction of the solutions 1 and 2 the water is basically removed by evaporation and/or vaporization, thus from the components of the solutions 1 and 2 in the microcavities there is formed a slightly water soluble deposit. Claims: 26
Patent MX-155834-A (MX)
Inventor: ULMER GEORGES
IPC: F02F11/00
Filed: 1983-05-27
Abstract: A cylinder head gasket has outwardly open grooves formed in the compressible refractory body around the fluid passages to be sealed and sealing strips received in the grooves so that webs of the strips lying along the bottoms of the grooves are set back from the faces of the gasket while wings of the strips overhang these faces adjoining the grooves.
Patent NZ-204487-A (NZ)
Title: 5-aroyl-6-alkylthio-1,2-dihydro-3h-pyrrolo(1,2-a)pyrrol-1-yl-carboxylic acid derivatives
Inventor: MUCHOWSKI J M
IPC: C07D487/04
Filed: 1983-06-07
Abstract: Novel 5-aroyl-6-methylthio-, 6-methylsulfinyl-, or 6-methylsulfonyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acids represented by the formulasand the pharmaceutically acceptable, non-toxic esters and salts thereof, whereinR, is lower alkylthio, lower alkylsulfinyl, or lower alkylsulfonyl;R<sub>2</sub> is hydrogen, hydroxy, lower alkyl, vinyl, cyclohexyl, cyclopropyl, lower alkoxy, fluoro, chloro, bromo, trifluoromethyl, trifluoromethoxy, nitro, amino, lower alkylcarbonylamino, lower alkylthio, lower alkylsulfonyl, or lower alkylsulfinyl;X is oxygen, sulfur, N-R<sub>3</sub> where R<sub>3</sub> is hydrogen or lower alkyl.This invention also describes intermediates of the process and the process for the production of these compounds and their pharmaceutically acceptable non-toxic salts and pharmaceutical composition thereof. The claimed compounds are useful as anti-inflammatories and analgesics in mammals.
Patent NZ-206212-A (NZ)
Title: Foaming liquid detergent compositions containing sulphosuccinic acid esters and alkyl ether sulphates
Inventor: EDGE D J
IPC: C11D1/83
Filed: 1983-11-09
Abstract: A high foaming aqueous liquid detergent composition suitable inter alia for manual dishwashing is based on a ternary active detergent system of (a) dialkyl sulphosuccinate, (b) alkylbenzene sulphonate and/or secondary alkane sulphonate and (c) alkyl ether sulphate. This combination gives both performance and formulation (viscosity, hydrot- ropy) benefits.
Patent NZ-206906-A (NZ)
Title: Substituted pyridazines and pyrimidines and pharmaceutical compositions
Inventor: BIZIERE K
IPC: C07D491/10
Filed: 1984-01-20
Abstract: The present invention relates to the compounds of formula   <IMAGE> in which X1 represents N or   <IMAGE>  X2 represents N or    <IMAGE> provided that X1 and X2 are different from each other; R1 and R2 being -(CH2)nOH wherein n is 1 to 4 or   <IMAGE>  represents a saturated heterocycle with 5 or 6 groupings containing one nitrogen atom as heteroatom, substituted in 3 or 4 position for example by (CH2)mOR6 where R6 is H or an acyl radical or an amido radical; to a process for preparing said compounds; and to the drugs containing said compounds active in particular on the central nervous system.
Patent NZ-210980-A (NZ)
Title: Activation of cobalt catalysts and preparation of hydrocarbons from carbon monoxide and hydrogen
Inventor: MINDERHOUD J K
IPC: B01J23/74
Filed: 1985-01-29
Abstract: The activation of Co/Zr/SiO2 catalysts prepared by impregnation and/or kneading is carried out at a temperature between 200 and 350 DEG C with a H2-containing gas under such conditions that a specified relation is met between on the one hand the applied space velocity (D), total pressure (PTot) and H2 partial pressure (PH2) and on the other hand the surface area (S), the Co load (L) and the Zr load (Z) of the catalyst. This relation reads: <CHEM>   In this way a catalyst with optimum stability is obtained.
Patent NZ-214076-A (NZ)
Title: 3-pyridinecarboxylate derivatives and herbicidal compositions
Inventor: LEE L F
IPC: C07F9/58
Filed: 1985-11-05
Abstract: There are disclosed novel 2,6-substituted-3-pyridinecarboxylic acids, esters, and salts useful as herbicides, and as intermediates which provide herbicides.
Patent NZ-217755-A (NZ)
Title: 2-(2-thienyl)-imidazo(4,5-c)pyridine derivatives and pharmaceutical compositions
Inventor: BINDER D
IPC: A61K31/44
Filed: 1986-09-30
Abstract: The invention relates to new 2-(2-thienyl)imidazo(4,5-c)pyridine derivatives of the formula    <IMAGE>  I  wherein R1 denotes lower alkyl, R2 denotes hydrogen or methyl and n denotes 0 or 1, and pharmaceutically usable acid addition salts thereof, a process for their preparation and pharmaceutical products containing these compounds. The new compounds and their salts have useful pharmacological properties, in particular a positively inotropic action on the heart, and can be used as active compounds for medicaments for the treatment of diseases of the heart and vessels, in particular myocardial insufficiency.
Patent NZ-225526-A (NZ)
Title: Odourless and tasteless tablets for the treatment of uraemia
Inventor: BOBEE JEAN-MARC
IPC: A61K31/195
Filed: 1988-07-22
Abstract: Pharmaceutical compositions containing a mixture of several salts of basic  alpha -amino acids and of  alpha -keto analogues of branched-chain essential amino acids, characterised in that they are presented in the form of a gastroresistant or gastrosoluble coated tablet.
Patent NZ-225554-A (NZ)
Title: Pyridylethanolamine derivatives and growth promoting compositions
Inventor: LINDEL HANS
IPC: C07D213/85
Filed: 1988-07-26
Abstract: Substituted pyridylethanolamines of the formula I 
<IMAGE>
 in which
 R<1> represents CN, -COOR<8> or -CONR<9>R<1><0>,
 R<2> represents optionally substituted alkyl,
 R<3> represents hydrogen, alkyl or alkenyl,
 R<4> represents hydrogen, optionally substituted alkyl or alkenyl,
 R<3> and R<4>, together with the nitrogen atom to which they are bonded, represent an optionally substituted heterocyclic radical,
 R<5> represents OH, acyloxy or alkoxy,
 R<6> represents hydrogen or alkyl,
 R<7> represents hydrogen, alkyl, cycloalkyl, substituted alkyl, optionally substituted aralkyl, aryl or heterocyclyl,
 R<6> and R<7>, together with the nitrogen atom to which they are bonded, can represent an optionally substituted heterocyclic radical,
 R<8> represents alkyl,
 R<9> and R<1><0> independently of one another represent hydrogen, alkyl or alkenyl, or together with the nitrogen atom to which they are bonded, represent an optionally substituted heterocyclic radical,
 and intermediates for carrying out these processes.
Patent NZ-232661-A (NZ)
Title: Manufacture of pyridine-2-carboxamides
Inventor: SCALONE MICHELANGELO
IPC: C07D213/81
Filed: 1990-02-23
Abstract: Prodn. of 5-chloro-2-pyridinecarboxamide derivs. of formula (I) is effected by: (a) reacting 2,5-dichloropyridine (II) with an alkyne of formula RICCH (III) in the presence of a Pd phosphine complex catalyst (IV), oxidising the resulting 2-alkynyl-5-chloropyridine (V) to form 5-chloro-2-pyridinecarboxylic acid (VI), and reacting (VI) or a reactive deriv. of (VI) with an amine of formula RCH2CH2NH2 (VII); or (b) reacting (II) with CO and (VII) in the presence of (IV); or (c) reacting (II) with CO and opt. an aq. lower alkanol in the presence of (IV) to form (VI) or a lower alkyl ester of (VI), and reacting this with (VII). In formulae, R1 = H, lower alkyl, SiMe3 or CR2R3OH; R2 and R3 = H or lower alkyl, or CR2R3 = cyclopentylene or cyclohexylene; R = NH2 or a gp. convertible to NH2. Pref. (IV) is (Ph3)2PdCl2 or is formed in situ from PdCl2 or Pd(OAc)2 and 1,3-bis(diphenylphosphino)propane (BDP).
Patent NZ-234726-A (NZ)
Title: 2,3-dihydro-1-(pyridinylamino)-indoles and pharmaceutical compositions
Inventor: EFFLAND RICHARD CHARLES
IPC: A61K31/4433
Filed: 1990-07-31
Abstract: This invention relates to 2,3-dihydro-1-(pyridinylamino)-indoles of the formula <CHEM> wherein R1 is hydrogen, loweralkyl, aryl, arylloweralkyl, alkenyl, alkynyl or heteroarylloweralkyl selected from the group consisting of pyridinylmethyl, pyridinylethyl, thienylmethyl, thienylethyl; R2 and R3 are independently hydrogen, loweralkyl, aryl, arylloweralkyl or heteroarylloweralkyl selected from the group consisting of pyridinylmethyl, pyridinylethyl, thienylmethyl, thienylethyl; or R2 and R3 together form a cycloalkane ring of 4 to 6 carbons or a spiro-fused aryl or heteroaryl cycloalkane; X and Y are independently hydrogen, halogen, hydroxy, loweralkyl, loweralkoxy, nitro, amino or trifluoromethyl; m and n are independently integers of 1 to 3, the pharmaceutically acceptable acid addition salts thereof and where appropriate, the optical, geometrical and stereoisomers and racemic mixtures thereof. The compounds of this invention are useful as analgesics, anticonvulsants, for enhancing memory and for the treatment of Alzheimer's disease.
Patent NZ-244662-A (NZ)
Title: Three chamber sequential combustion apparatus for refuse: chamber and apparatus walls cooled and ambient combustion air heated
Inventor: JONG JOHANNES DE
IPC: F23G5/027
Filed: 1992-10-08
Abstract: Apparatus for utilising the energy of waste matte comprises respective gasification and combustion chambers (2, 3) connected by an intermediate chamber (4), an entry (5) for ambient combustion air into at least the intermediate chamber (4), and means (6) to cool an inner and external wall of the apparatus and heat the ambient combustion air for passage to the entry (5). <IMAGE>
Patent NZ-249465-A (NZ)
Title: 2,3,4,5-tetrahydro-1h-3-benzazepine derivative, preparation and pharmaceutical compostions thereof
Inventor: FOGED CHRISTIAN
IPC: A61P25/24
Filed: 1993-02-05
Abstract: 2,3,4,5-Tetrahydro-1H-3-benzazepines having general formula (I) wherein R<1> is Cl or Br; R<3> and R<4> are hydrogen, halogen, CF3, CN, NO2, or NH2. The compounds are useful in treatment of certain disorders in the central nervous system.
Patent NZ-259858-A (NZ)
Title: Use of galanthamine in treating nicotine dependence; sustained release formulations
Inventor: MOORMANN JOACHIM ARNOLD
IPC: A61K31/55
Filed: 1994-01-10
Abstract: PCT No. PCT/EP94/00055 Sec. 371 Date Oct. 30, 1995 Sec. 102(e) Date Oct. 30, 1995 PCT Filed Jan. 10, 1994 PCT Pub. No. WO94/16708 PCT Pub. Date Aug. 4, 1994The present invention relates to the use of galanthamine and the pharmaceutically acceptable acid addition salts thereof for the treatment of nicotine dependence. The active substances are released from pharmaceutical formulations, e.g., orally, transdermally, or otherwise parenterally in a continuous and controlled manner.
Patent NZ-261140-A (NZ)
Title: Composite reverse osmosis membrane having a layer of crosslinked polyol(polyhydric compound) laminated to a support membrane
Inventor: COLQUHOUN HOWARD MATTHEW
IPC: B01D69/12
Filed: 1994-02-02
Abstract: PCT No. PCT/GB94/00198 Sec. 371 Date Oct. 11, 1995 Sec. 102(e) Date Oct. 11, 1995 PCT Filed Feb. 2, 1994 PCT Pub. No. WO94/17905 PCT Pub. Date Aug. 18, 1994A reverse osmosis membrane having a support which itself has properties of salt rejection laminated to a layer of a cross-linked polyol. The support is a sulphonated aromatic polyether sulphone, and the polyol ma be polyvinyl alcohol.
Patent NZ-264037-A (NZ)
Title: Benzospiroalkene derivatives and pharmaceutical compositions
Inventor: CORDI ALEX
IPC: C07D495/10
Filed: 1994-07-19
Abstract: Compounds of formula (I): <IMAGE>  in which:   - X represents -CH2-, -(CH2)2-, -CH=CH-, -O-CH2-, -S-CH2-, -SO-CH2- or -SO2-CH2-,   - Y represents an oxygen or sulphur atom or a group -NR5-, - R represents a halogen atom, a linear or branched (C1-C6)alkyl group (substituted or unsubstituted), a hydroxyl group or a linear or branched (C1-C6)alkoxy group, - R2 represents a hydrogen or halogen atom, a linear or branched (C1-C6)alkyl group (substituted or unsubstituted), a hydroxyl group, a linear or branched (C1-C6)alkoxy group or a linear or branched (C1-C6)alkylthio group, - R3 represents a hydrogen or halogen atom, a linear or branched (C1-C6)alkyl group (substituted or unsubstituted), a hydroxyl group, a linear or branched (C1-C6)alkoxy group or a linear or branched (C1-C6)alkylthio group, - R4 represents a hydrogen atom or an amino group (substituted or unsubstituted), - R5 represents a hydrogen atom or a linear or branched (C1-C6)alkyl group, or else -R1 and R2 form, together with the carbon atoms which carry them, a benzene ring, provided that, in this case, X represents -CH2- or -(CH2)2-, their isomers and their addition salts with a pharmaceutically acceptable acid. Medicaments.
Patent NZ-265412-A (NZ)
Title: Creating fold in sheet material: fold containing elastic thread.
Inventor: JOHANSSON DAN
IPC: A61F13/49
Filed: 1994-04-21
Abstract: PCT No. PCT/SE94/00355 Sec. 371 Date Nov. 9, 1995 Sec. 102(e) Date Nov. 9, 1995 PCT Filed Apr. 21, 1994 PCT Pub. No. WO94/23681 PCT Pub. Date Oct. 27, 1994The present invention relates to a method and to an arrangement for creating in a web (1) of sheet material a fold which includes at least one elastic thread (4). The web is placed on two mutually separated carrier elements (2, 3), and at least one prestretched elastic thread (4) is placed over the web in the space between the opposing edges of the carrier elements. The carrier elements are moved towards one another at the same time as the elastic thread or threads is/are moved down in the space between the carrier elements in abutment with the material web and in keeping with the rate at which the carrier elements are brought together, until at least one of the two opposing edges of the carrier elements, which approach one another as they are brought together, reaches the movement path of an elastic thread, wherein those parts of the web which abut one another when the carrier elements have been brought together to a mutually combined state are mutually joined along a line which extends transversely in relation to the direction in which the carrier elements are brought together.
Patent NZ-281355-A (NZ)
Title: Piperidine-4-carboxamide derivatives; local anaesthetic and analgesic use
Inventor: ASK ANNA-LENA
IPC: A61K31/535
Filed: 1995-02-03
Abstract: New compounds of the formula (A) a process for their preparation and their use in the manufacture of pharmaceutical preparations. The new compounds have both local anaesthetic and analgesic effect.
Patent NZ-299394-A (NZ)
Title: Producing high-titer immunoglobulin preparations from blood plasma using affinity chromatography
Inventor: AMSTUTZ HANSPETER
IPC: C07K16/00
Filed: 1996-09-16
Abstract: Prodn. of a high-titre immunoglobulin (Ig) prepn. comprises: (a) fractionating blood plasma from a plasma pool to separate ≥ 1 industrially utilisable polyclonal IgG fraction from a residual fraction; (b) preparing a protein soln. from the protein components of the residual fraction or its subfractions; (c) subjecting the protein soln. to ≥ 1 affinity chromatography step in which specific plasma proteins are bound to immobilised ligands of ≥ 1 type and the bound proteins are then released, and (d) converting the released proteins into a high-titre Ig prepn.
Patent NZ-332108-A (NZ)
Title: Support comprising rotatable, rod retention means angled with respect to a base portion
Inventor: KEESING KENNETH BERNARD
IPC: A01K97/10
Filed: 1999-09-21
Abstract: support 1, for a substantially elongate object, e.g. a fishing rod, includes a base portion 2 and at least one substantially elongate retention means, e.g. tube 3, for receiving and/or retaining a portion of the elongate object.  The retention means 3 extends from (or into) the base portion and is angled with respect thereto.  The retention means 3 is free to rotate about an axis 5 that is substantially perpendicular with respect to the main plane of the base portion.  The base portion may comprise part of or may be incorporated into or onto the surface 7 of a boat.  The support may be provided with an actuating means, e.g. button 8, which allows the retention means to move with respect to the base portion.
Patent NZ-502044-A (NZ)
Title: Cascade refrigeration process for liquefaction of natural gas
Inventor: COLE ERIC T
IPC: C22C38/14
Filed: 1998-06-18
Abstract: A pressurized gas stream (10) rich in methane is introduced into heat exchange contact with a first refrigerant cycle (32) comprising at least one refrigeration stage (30-31) whereby the gas stream is cooled against a first portion of a first refrigerant to produce a cooled gas stream. The cooled gas stream is then introduced into heat exchange contact with a second refrigerant cycle (33) comprising at least one refrigeration stage (37-39) whereby the cooled gas stream is further cooled to produce a liquefied methane-rich stream (20) having a temperature above about -112 °C and a pressure sufficient for the liquefied stream to be at or below its bubble point.  The liquefied stream is stored above -112 °C in specially constructed tanks 41.  The refrigerant used in the second refrigerant stage has a boiling point lower than the boiling point of the refrigerant of the first refrigerant stage and is partially cooled and condensed by heat exchange with a second portion of the first refrigerant.
Patent NZ-502062-A (NZ)
Title: Process for manufacturing paroxetine solid dispersions
Inventor: TELEHA CHRISTOPHER A
IPC: A61K31/445
Filed: 1998-06-26
Abstract: A composition, and process for preparing a water-soluble solid-state dispersion of paroxetine salt and a pharmaceutically acceptable carrier. The process involves forming a solution of a water-soluble pharmaceutically acceptable carrier with a non-aqueous solvent, dissolving paroxetine free base into the solution the ratio of carrier to paroxetine in the range of 4:1 to 1 :1, adding a non-toxic inorganic or organic acid to form a pharmaceutically acceptable non-crystalline paroxetine salt anhydrate in solution, then removing the solvent by evaporation under vacuum.  The water-soluble solid-state dispersion of non-crystalline paroxetine salt anhydrate composition produced by the process is used to treat depression.
Patent NZ-505105-A (NZ)
Title: Method and apparatus for cleaning poultry with one flood nozzle to fill birds internal cavity, and spray nozzles to clean outside of birds
Inventor: MOSTOLLER CHARLES P
IPC: A23B4/30
Filed: 1998-12-11
Abstract: An apparatus is disclosed for use for reducing the amount of pathogenic bacteria associated with a bird or other edible animal, and preferably chickens, comprising: (a) a unit (12) having an interior portion having side and bottom walls, an exterior portion having side and bottom walls and end walls connecting said interior portion to said exterior portion wherein the area of said interior portion provides a space which completely surrounds one or more of the birds or animals being treated; (b) one or more flood nozzles (24) mounted within said interior portion of said unit and connected to a source of a bacteria reducing chemical solution to enable the bacteria reducing chemical solution to be applied to the entire interior of the body cavity of the bird or animal being treated; (c) one or more spray nozzles (20) mounted within said interior portion of said unit and connected to a source of a bacteria reducing chemical solution to enable the bacteria reducing chemical solution to be applied to the entire external surfaces of the bird or animal being treated; and (d) one or more lines (28) for connecting said one or more flood nozzles and said one or more spray nozzles to the source of the bacteria reducing chemical solution.
Patent NZ-509289-A (NZ)
Title: Compostion for the protective treatment of wood comprises coal-tar oil and a quateranry ammonium compound with water
Inventor: MARX HANS-NORBERT
IPC: B27K3/44
Filed: 1999-07-02
Abstract: A composition for the protective treatment of wood against rot and attack by insects comprises: a) 5-90 parts per unit mass of coal tar oil; b) 2-20 parts per unit mass of a biocidally active quaternary ammonium compound and c) 10-90 parts per unit mass of water.
Patent NZ-510739-A (NZ)
Title: Neuroimmunophilins for selective neuronal radioprotection
Inventor: KEEP MARCUS
IPC: A61K38/12
Filed: 1998-09-23
Abstract: A neuroimmunophilin ligand is used in the preparation of a composition for selectively reducing neuronal damage or death in normal neuroimmunophilin-rich neurons of central and autonomic nervous system while offering reduced or no protection to neuroimmunophilin-poor glia, glia-derived tumor cells, abnormal neuron-derived tumor cells, non-brain tumors and non-neuron tissue of the body from ionizing radiation. The ligand is preferably selected from cyclosporine A, cyclosporins, FK506, cyclophilin-type neuroimmunophilin ligands and combination thereof. The ligand can be used in the preparation of a composition for selectively ionizing radiation treatment of a patient or for effective neuron radioprotection treatment.
Patent NZ-515237-A (NZ)
Title: Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
Inventor: LINK JAMES
IPC: C07D295/26
Filed: 2000-04-03
Abstract: Described are cinnamide compounds of formula (I), in which at least one of R1 to R5 is a "cis-cinnamide" or a "trans-cinnamide" that are useful for treating inflammatory and immune diseases, pharmaceutical compositions containing these compounds and methods of inhibiting inflammation or suppressing immune response in a non-human mammal; Wherein R1, R2, R3, R4, and R5 are independently selected from hydrogen, halogen, alkyl, haloalkyl, alkoxy, cyano, nitro, carboxaldehyde, and with the proviso that at least one of R1 or R3 is a "cis-cinnamide" or a "trans-cinnamide", and Ar is a substituted aryl or substituted heteroaryl group, where substitutions are independently selected from hydrogen, halogen, alkyl, aryl, haloalkyl, hydroxy, alkoxy, alkoxyalkyl, alkoxycarbonyl, alkoxyalkoxy, hydroxyalkyl, aminoalkyl, aminocarbonyl, alkyl (alkoxycarbonylalkyl)aminoalkyl, heterocyclyl, substituted heterocyclyl, heterocyclylalkyl, substituted heterocyclylalkyl, carboxaldehyde, carboxaldehyde hydrazone, carboxamide, alkoxycarbonylalkyl, carboxy, carboxyalkyl, carboxyalkoxy, carboxythioalkoxy, carboxycycloalkoxy, thioalkyl, hydroxycarbonylalkyl (carboxyalkyl), hydroxyalkylaminocarbonyl, cyano, amino, heterocyclylalkylamino, carboxyalkylamino, heterocyclylalkylaminocarbonyl, and a "trans-cinnamide", or a pharmaceutically-acceptable salt or prodrug thereof.